SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

The antiviral therapy is already recommended for an estimated 3.9 million people who do not need supplemental oxygen for COVID-19 and who have an increased risk for progression to severe COVID-19.

Paxlovid is an antiviral therapy that helps your body fight off COVID-19 faster and more effectively. In one clinical trial, Paxlovid was 89% effective in reducing hospitalization and death in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Antiviral therapy reduced incidence of long COVID-19 ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear. Research studies ...

A single oral antiviral that works against common colds, influenza, COVID-19, and other respiratory infections sounds like ...